Levee Medical has secured over $12m in additional financing to support the PMA process as the ARID II Trial of the Voro Urologic Scaffold progresses.

QuidelOrtho has signed a strategic supply agreement with Lifotronic Technology to expand its global immunoassay portfolio.

Medtronic has received the US Food and Drug Administration (FDA) clearance for the Stealth AXiS spine surgery robotics ...

Despite the growing burden of kidney disease, a complex array of issues in the US and worldwide makes innovation in the space particularly difficult.

Merck and Calla Lily Clinical Care have announced a strategic partnership to advance Callavid, an intravaginal drug delivery platform.

LEX Diagnostics has secured the US FDA 510(k) clearance and CLIA waiver for its VELO system, a PCR point-of-care diagnostics platform for respiratory pathogens.

Edwards’ financials reveal that its transcatheter mitral and tricuspid therapies (TMTT) portfolio grew by 56.4% in 2025.

In its Q1 fiscal 2026 financials, BD trimmed its EPS outlook by more than $2 at the high end due to the spin-off of its ...

Elumn8 Medical has announced the initial close of its Series C funding and rebrand from Simpson Interventions to Elumn8 Medical.

AngioDynamics has expanded indications across Europe for its NanoKnife System to include soft tissue ablation.

VB Spine is to acquire Augmedics’ xvision Spine System to add augmented reality (AR) navigation to its enhanced visualisation offerings.

The UK government has set out to improve access to healthcare technology within the National Health Service (NHS) through the ...